Safe Surf Rated - www.safesurf.com Back To Home Page Family Friendly Site - www.familyfriendlysites.com
About
Bradford
  HIV/AIDS
Articles
  Alternative
Therapies
  HIV/AIDS
Videos
  HIV/AIDS
Links
  HIV/AIDS
News

Introduction:
Positively Positive
- Living with HIV
  Out
About
HIV
  Resume/
Curriculum Vitae:
HIV / AIDS Involvements
  Biography   HIV/AIDS
News Archive
HIV and AIDS News spacer.gif Bradford McIntyre spacer.gif
spacer.gif
   
AIDS Awareness Red Ribbon


bioLytical Laboratories Inc. - www.biolytical.com

BIOLYTICALS INSTI HIV ASSAY RECEIVES FDA APPROVAL FOR HIV-2

Press Release

RICHMOND, B.C., Feb. 24, 2015 - bioLytical Laboratories Inc., a leading manufacturer of point-of-care rapid diagnostic tests, announced today that it has received U.S. Food and Drug Administration (FDA) approval of its INSTI HIV Antibody Test for use in detecting antibodies to HIV type 2 (HIV-2). With this approval, the INSTI HIV-1/2 Antibody Test is available for use in detecting HIV-1 and HIV-2 antibodies in as little as 60 seconds.

Centers for Disease Control and Prevention (CDC) estimates that over 1.2 million persons aged 13 years and older are living with HIV infection in the United States, including over 168,300 (14%) who are unaware of their infection.1 With the ability to expand into more public health bodies and hospital markets, bioLytical will be able to better serve its community through more readily available HIV testing. The Company is excited to add the HIV-2 claim to its already impressive regulatory approval credentials, including those from Health Canada and the European Union, the World Health Organization (Prequalification) and the U.S. FDA. INSTI's FDA approval also includes a "CLIA" waiver which allows the test to be administered outside of a laboratory setting by anyone who has been trained in its use - an important consideration in global seek and treat testing initiatives. Providing HIV testing services in non-clinical venues facilitates access for individuals who may not access these services through other health care providers, those who may be testing for the first time, or those at highest risk of acquiring HIV who would benefit from repeated testing.

Mr. Robert Mackie, Executive Chairman of bioLytical Laboratories, is proud of the many accomplishments the bioLytical team has achieved as the Company surpasses yet another major milestone. We are expanding our sales force in multiple U.S. markets to support our revenue growth model and to continue to provide best in class service to our customers. The FDA approved and CLIA waived INSTI HIV-1/2 test will allow bioLytical to further successfully penetrate the U.S. market to increase market share.

INSTI was developed for the detection of antibodies to both HIV types and so the FDA approved HIV-2 claim will allow bioLytical to expand its markets further in the United States as some health departments require it for their testing programs. We are thrilled to have obtained the HIV-2 designation, said Rick Galli, Chief Technical Officer of bioLytical Laboratories.

###

About bioLytical Laboratories
bioLytical Laboratories is a privately owned Canadian company engaged in the research, development and commercialization of rapid, point-of-care in vitro medical diagnostics using its proprietary INSTI technology platform. Today, the company markets and sells its signature INSTI HIV test and has a world-wide footprint of regulatory approvals including U.S. FDA approval, Health Canada approval and CE mark from European regulators. Their product provides a highly accurate HIV test result in as little as 60 seconds translating into a compelling value proposition for patients, healthcare professionals and public health organizations. For more information on bioLytical Laboratories, please visit www.biolytical.com.



CONTACT
Mr. Robert Mackie
(604) 204-6784
info@biolytical.com



Source: bioLytical Laboratories
http://www.biolyticalcanada.com/pri.asp?pressID=439


"Reproduced with permission - bioLytical Laboratories"

bioLytical Laboratories
www.bioLytical.com


For more HIV and AIDS News visit...

Positively Positive - Living with HIV/AIDS:
HIV/AIDS News


...positive attitudes are not simply 'moods'

Site Map

Contact Bradford McIntyre.

Web Design by Trevor Uksik
uks.jpg

Copyright © 2003-2017 Bradford McIntyre. All rights reserved.

DESIGNED TO CREATE HIV & AIDS AWARENESS

spacer.gif